168 related articles for article (PubMed ID: 12183237)
1. Penciclovir susceptibilities of herpes simplex virus isolates from patients using penciclovir cream for treatment of recurrent herpes labialis.
Sarisky RT; Bacon T; Boon R; Locke L; Nguyen TT; Leary J; Esser K; Saltzman R
Antimicrob Agents Chemother; 2002 Sep; 46(9):2848-53. PubMed ID: 12183237
[TBL] [Abstract][Full Text] [Related]
2. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
[TBL] [Abstract][Full Text] [Related]
3. Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis.
Bacon TH; Boon RJ; Schultz M; Hodges-Savola C
Antimicrob Agents Chemother; 2002 Sep; 46(9):3042-4. PubMed ID: 12183267
[TBL] [Abstract][Full Text] [Related]
4. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of herpes simplex virus isolates to nucleoside analogues and the proportion of nucleoside-resistant variants after repeated topical application of penciclovir to recurrent herpes labialis.
Shin YK; Weinberg A; Spruance S; Bernard M; Bacon TH; Boon RJ; Levin MJ
J Infect Dis; 2003 Apr; 187(8):1241-5. PubMed ID: 12696003
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
Standring-Cox R; Bacon TH; Howard BA
J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
[TBL] [Abstract][Full Text] [Related]
7. Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.
Suzutani T; Ishioka K; De Clercq E; Ishibashi K; Kaneko H; Kira T; Hashimoto K; Ogasawara M; Ohtani K; Wakamiya N; Saijo M
Antimicrob Agents Chemother; 2003 May; 47(5):1707-13. PubMed ID: 12709344
[TBL] [Abstract][Full Text] [Related]
8. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
[TBL] [Abstract][Full Text] [Related]
10. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.
Piret J; Boivin G
Antimicrob Agents Chemother; 2011 Feb; 55(2):459-72. PubMed ID: 21078929
[TBL] [Abstract][Full Text] [Related]
11. Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection.
McKeough MB; Spruance SL
Arch Dermatol; 2001 Sep; 137(9):1153-8. PubMed ID: 11559210
[TBL] [Abstract][Full Text] [Related]
12. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
13. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials.
Raborn GW; Martel AY; Lassonde M; Lewis MA; Boon R; Spruance SL;
J Am Dent Assoc; 2002 Mar; 133(3):303-9. PubMed ID: 11934185
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs.
Kern ER; Palmer J; Szczech G; Painter G; Hostetler KY
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):501-13. PubMed ID: 10772730
[TBL] [Abstract][Full Text] [Related]
15. The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo.
Neyts J; Andrei G; De Clercq E
Antimicrob Agents Chemother; 1998 Feb; 42(2):216-22. PubMed ID: 9527762
[TBL] [Abstract][Full Text] [Related]
16. Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines.
Leary JJ; Wittrock R; Sarisky RT; Weinberg A; Levin MJ
Antimicrob Agents Chemother; 2002 Mar; 46(3):762-8. PubMed ID: 11850259
[TBL] [Abstract][Full Text] [Related]
17. Comparison of methods for identifying resistant herpes simplex virus and measuring antiviral susceptibility.
Sarisky RT; Crosson P; Cano R; Quail MR; Nguyen TT; Wittrock RJ; Bacon TH; Sacks SL; Caspers-Velu L; Hodinka RL; Leary JJ
J Clin Virol; 2002 Jan; 23(3):191-200. PubMed ID: 11595598
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory action of acyclovir (ACV) and penciclovir (PCV) on plaque formation and partial cross-resistance of ACV-resistant varicella-zoster virus to PCV.
Hasegawa T; Kurokawa M; Yukawa TA; Horii M; Shiraki K
Antiviral Res; 1995 Jun; 27(3):271-9. PubMed ID: 8540749
[TBL] [Abstract][Full Text] [Related]
19. Characterization of DNA polymerase-associated acyclovir-resistant herpes simplex virus type 1: mutations, sensitivity to antiviral compounds, neurovirulence, and in-vivo sensitivity to treatment.
Wang LX; Takayama-Ito M; Kinoshita-Yamaguchi H; Kakiuchi S; Suzutani T; Nakamichi K; Lim CK; Kurane I; Saijo M
Jpn J Infect Dis; 2013; 66(5):404-10. PubMed ID: 24047739
[TBL] [Abstract][Full Text] [Related]
20. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir Cream Herpes Labialis Study Group.
Boon R; Goodman JJ; Martinez J; Marks GL; Gamble M; Welch C
Clin Ther; 2000 Jan; 22(1):76-90. PubMed ID: 10688392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
